• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Calcitonin Gene Related Peptide II, human

Calcitonin Gene Related Peptide II, human

Product ID C0250
Cas No.
Purity ≥95%
Product Unit SizeCostQuantityStock
0.5 mg $409.00 In stock
1 mg $695.00 In stock
2.5 mg $1,227.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Calcitonin gene-related peptide II (CGRP II) exhibits vasodilatory and gastrointestinal modulatory activities; it also appears to be associated with inflammation in diseases such as gout and rheumatoid arthritis. CGRP II dilates arterioles in vitro and inhibits pentagastrin-stimulated gastric acid secretion in clinical settings. Like CGRP, this peptide likely binds RAMP1 and CGRP receptors.

Product Info

Purity

≥95%

Formula

C162H267N51O48S3

Formula Wt.

3793.38

Synonym

CGRP II, β-CGRP

Solubility

Soluble in water.

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

C0250 MSDS PDF

Info Sheet

C0250 Info Sheet PDF

References

Vanner S. Mechanism of action of capsaicin on submucosal arterioles in the guinea pig ileum. Am J Physiol. 1993 Jul;265(1 Pt 1):G51-5. PMID: 8338172.

Hernanz A, De Miguel E, Romera N, et al. Calcitonin gene-related peptide II, substance P and vasoactive intestinal peptide in plasma and synovial fluid from patients with inflammatory joint disease. Br J Rheumatol. 1993 Jan;32(1):31-5. PMID: 7678534.

Beglinger C, Born W, Hildebrand P, et al. Calcitonin gene-related peptides I and II and calcitonin: distinct effects on gastric acid secretion in humans. Gastroenterology. 1988 Oct;95(4):958-65. PMID: 2900791.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • D3447

    Diltiazem Hydrochloride

    Benzothiazepine; L-type Ca2+ channel blocker, p...

    ≥98%
  • M1876

    16-O-Methylcafestol

    Diterpene cafestol derivative found in coffee b...

    ≥98%
  • N3478

    Nitrendipine

    Calcium channel blocker.

    ≥98%
  • I0417

    R-(−)-Iberin

    Sulforaphane homolog, ITC found in cruciferous ...

    ≥98%
  • L930280

    LXH254

    pan-RAF inhibitor

    ≥99%
  • S0253

    Sanguinarine

    Benzophenanthridine alkaloid found in various p...

    ≥98%
  • D178589

    1-Deoxynojirimycin

    Anti-diabetic alkaloid

    ≥98%
  • A5301

    Anacetrapib

    Cholesterol ester transfer protein inhibitor.

    ≥98%
  • G3554

    Ginsenoside Rb3

    Triterpene saponin found in species of Panax.

    ≥98%
  • S3313

    Sildenafil Citrate

    PDE5/6 inhibitor.

    ≥99%
  • S3584

    Sivelestat Sodium Tetrahydrate

    Neutrophil elastase inhibitor.

    ≥99%
  • A9617

    Azelnidipine

    Dihydropyridine; L-type Ca2+ channel blocker.

    ≥98%
  • O486188

    Omeprazole Impurity F and G mixture

    Regioisomers

    ≥98%
  • G1210

    GDC-0623

    MEK inhibitor.

    ≥98%
  • A7656

    Atomoxetine Hydrochloride

    NET and SERT inhibitor, NMDA antagonist.

    ≥99%
  • A0833

    Acipimox

    Niacin derivative.

    ≥98%
  • L5658

    Lonidamine

    Hexokinase inhibitor, aerobic glycolysis inhibi...

    ≥98%
  • G733400

    GSK-2578215A

    Selective inhibitor of LRRK2.

    ≥98%
  • L8261

    Lupeol

    Triterpene; potential tyrosinase inhibitor.

    ≥98%
  • C3210

    Ciglitazone

    Thiazolidinedione; PPARγ agonist.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only